TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $1,047,319,000 | +87.3% | 38,029 | +12.1% | 0.00% | – |
Q1 2021 | $559,176,000 | -32.6% | 33,910 | -24.6% | 0.00% | – |
Q4 2020 | $829,350,000 | +61.6% | 45,000 | +19.4% | 0.00% | – |
Q3 2020 | $513,097,000 | +53.1% | 37,700 | +101.6% | 0.00% | – |
Q2 2020 | $335,104,000 | -19.1% | 18,700 | -54.8% | 0.00% | – |
Q3 2018 | $414,000,000 | -20.9% | 41,400 | 0.0% | 0.00% | – |
Q2 2018 | $523,710,000 | – | 41,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Advisors, Inc. | 1,872,115 | $30,871,000 | 5.70% |
FRAZIER MANAGEMENT LLC | 2,182,789 | $35,994,000 | 2.89% |
Baupost Group | 18,044,239 | $295,810,000 | 2.36% |
RTW INVESTMENTS, LP | 4,382,199 | $72,262,000 | 1.13% |
DAFNA Capital Management LLC | 225,393 | $3,717,000 | 0.88% |
Camber Capital Management LP | 1,150,000 | $18,964,000 | 0.65% |
EcoR1 Capital, LLC | 596,900 | $9,843,000 | 0.44% |
Alpha Paradigm Partners, LLC | 50,393 | $831,000,000 | 0.32% |
Birchview Capital, LP | 30,000 | $495,000 | 0.29% |
Artal Group S.A. | 1,000,000 | $16,490,000 | 0.29% |